RA Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $70.5M | Sell |
|
|||||
|
2018
Q4 | $86M | Buy |
|
|||||
|
2018
Q3 | $70.5M | Buy |
|
|||||
|
2018
Q2 | $40M | Hold |
|
|||||
|
2018
Q1 | $33.3M | Hold |
|
|||||
|
2017
Q4 | $34.3M | Hold |
|
|||||
|
2017
Q3 | $36.6M | Buy |
|
|||||
|
2017
Q2 | $28.7M | Buy |
|
|||||
|
2017
Q1 | $29.3M | Buy |
|
|||||
|
2016
Q4 | $18.9M | Hold |
|
|||||
|
2016
Q3 | $13.2M | Hold |
|
|||||
|
2016
Q2 | $8.49M | Hold |
|
|||||
|
2016
Q1 | $8.46M | Sell |
|
|||||
|
2015
Q4 | $31.9M | Buy |
|
|||||
|
2015
Q3 | $13.6M | Sell |
|
|||||
|
2015
Q2 | $38.9M | Sell |
|
|||||
|
2015
Q1 | $62.5M | Sell |
|
|||||
|
2014
Q4 | $85.7M | Sell |
|
|||||
|
2014
Q3 | $69.1M | Buy |
|
|||||
|
2014
Q2 | $40.8M | Sell |
|
|||||
|
2014
Q1 | $46M | Hold |
|
|||||
|
2013
Q4 | $33M | Sell |
|
|||||
|
2013
Q3 | $42.5M | Buy |
|